Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: Relevance to atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 127, Issue 6, 2011, Pages

  Zhang, Bodi ^a   Alysandratos, Konstantinos Dionysios ^a,c   Angelidou, Asimenia ^a,c   Asadi, Shahrzad ^a   Sismanopoulos, Nikolaos ^a   Delivanis, Danae Anastasia ^a   Weng, Zuyi ^a   Miniati, Alexandra ^a,c   Vasiadi, Magdalini ^a,c   Katsarou Katsari, Alexandra ^c   Miao, Benchun ^b   Leeman, Susan E ^d   Kalogeromitros, Dimitrios ^c   Theoharides, Theoharis C ^a,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atopic dermatitis; degranulation; inflammation; mast cells; mitochondria; substance P; TNF

Indexed keywords

CALCINEURIN; DYNAMIN; DYNAMIN RELATED PROTEIN 1; IMMUNOGLOBULIN E; SMALL INTERFERING RNA; SUBSTANCE P; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATOPIC DERMATITIS; CELL CULTURE; CELL DIVISION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EXOCYTOSIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY OF ALLERGIC DISEASES 2 MAST CELL; MALE; MAST CELL DEGRANULATION; MITOCHONDRION; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; SKIN BIOPSY; TRANSMISSION ELECTRON MICROSCOPY; UMBILICAL CORD;

EID: 79957839365     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.02.005     Document Type: Article

References (51)

1. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005;6:135-42. (Pubitemid 40268194)
2. Theoharides TC, Kalogeromitros D. The critical role of mast cell in allergy and inflammation. Ann N Y Acad Sci 2006;1088:78-99. (Pubitemid 47092046)
3. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 1990;346:274-6.
4. Olszewski MB, Groot AJ, Dastych J, Knol EF. TNF trafficking to human mast cell granules: mature chain-dependent endocytosis. J Immunol 2007;178:5701-9. (Pubitemid 46674366)
5. Gibbs BF, Wierecky J, Welker P, Henz BM, Wolff HH, Grabbe J. Human skin mast cell rapidly release preformed and newly generated TNF-alpha and IL-8 following stimulation with anti-IgE and other secretagogues. Exp Dermatol 2001;10:312-20. (Pubitemid 32916280)
6. Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 2007;123:398-410.
7. O'Connor TM, O'Connell J, O'Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol 2004;201:167-80. (Pubitemid 39305095)
8. Beutler B. TNF, immunity and inflammatory disease: lessons of the past decade. J Investig Med 1995;43:227-35.
9. Haas RH. Autism and mitochondrial disease. Dev Disabil Res Rev 2010;16:144-53.
10. Siraganian RP. Mast cell signal transduction from the high-affinity IgE receptor. Curr Opin Immunol 2003;15:639-46. (Pubitemid 37434071)
11. Kraft S, Rana S, Jouvin MH, Kinet JP. The role of the FcepsilonRI beta-chain in allergic diseases. Int Arch Allergy Immunol 2004;135:62-72. (Pubitemid 39279433)
12. Blank U, Rivera J. The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol 2004;25:266-73. (Pubitemid 38501673)
13. Suzuki R, Furuno T, McKay DM, Wolvers D, Teshima R, Nakanishi M, et al. Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J Immunol 1999;163:2410-5. (Pubitemid 29399159)
14. Tuluc F, Lai JP, Kilpatrick LE, Evans DL, Douglas SD. Neurokinin 1 receptor isoforms and the control of innate immunity. Trends Immunol 2009;30:271-6.
15. Tatemoto K, Nozaki Y, Tsuda R, Konno S, Tomura K, Furuno M, et al. Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors. Biochem Biophys Res Commun 2006;349:1322-8. (Pubitemid 44416402)
16. Douglas WW, Kagayama M. Calcium and stimulus-secretion coupling in the mast cell: stimulant and inhibitory effects of calcium-rich media on exocytosis. J Physiol 1977;270:691-703. (Pubitemid 8170343)
17. Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006;125:1241-52. (Pubitemid 43929096)
18. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005;39: 359-407. (Pubitemid 43011120)
19. Morris RL, Hollenbeck PJ. The regulation of bidirectional mitochondrial transport is coordinated with axonal outgrowth. J Cell Sci 1993;104(pt 3):917-27. (Pubitemid 23123484)
20. Li Z, Okamoto K, Hayashi Y, Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004;119:873-87. (Pubitemid 40017692)
21. Molina AJ, Wikstrom JD, Stiles L, Las G, Mohamed H, Elorza A, et al. Mitochondrial networking protects beta-cells from nutrient-induced apoptosis. Diabetes 2009;58:2303-15.
22. Campello S, Lacalle RA, Bettella M, Manes S, Scorrano L, Viola A. Orchestration of lymphocyte chemotaxis by mitochondrial dynamics. J Exp Med 2006;203:2879-86. (Pubitemid 46026165)
23. Bleazard W, McCaffery JM, King EJ, Bale S, Mozdy A, Tieu Q, et al. The dynamin-related GTPase Dnm1 regulates mitochondrial fission in yeast. Nat Cell Biol 1999;1:298-304. (Pubitemid 129495781)
24. Praefcke GJ, McMahon HT. The dynamin superfamily: universal membrane tubulation and fission molecules? Nat Rev Mol Cell Biol 2004;5:133-47.
25. Youle RJ, Karbowski M. Mitochondrial fission in apoptosis. Nat Rev Mol Cell Biol 2005;6:657-63. (Pubitemid 41081269)
26. Knott AB, Perkins G, Schwarzenbacher R, Bossy-Wetzel E. Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 2008;9:505-18. (Pubitemid 351873464)
27. Kempuraj D, Saito H, Kaneko A, Fukagawa K, Nakayama M, Toru H, et al. Characterization of mast cell-committed progenitors present in human umbilical cord blood. Blood 1999;93:3338-46. (Pubitemid 29220901)
28. Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, Beaven MA, et al. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk Res 2003;27:677-82. (Pubitemid 36683255)
29. Dagda RK, Cherra SJ III, Kulich SM, Tandon A, Park D, Chu CT. Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem 2009;284:13843-55.
30. Theoharides TC, Zhang B, Kempuraj D, Tagen M, Vasiadi M, Angelidou A, et al. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci U S A 2010;107:4448-53.
31. Johnson RG, Carty SE, Fingerhood BJ, Scarpa A. The internal pH of mast cell granules. FEBS Lett 1980;120:75-9.
32. Theoharides TC, Singh LK, Boucher W, Pang X, Letourneau R, Webster E, et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects. Endocrinology 1998;139:403-13. (Pubitemid 28166335)
33. Cassidy-Stone A, Chipuk JE, Ingerman E, Song C, Yoo C, Kuwana T, et al. Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev Cell 2008;14:193-204. (Pubitemid 351189177)
34. Cereghetti GM, Stangherlin A, Martins de BO, Chang CR, Blackstone C, Bernardi P, et al. Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc Natl Acad Sci U S A 2008;105:15803-8.
35. Prabhakar NR, Runold M, Kumar GK, Cherniack NS, Scarpa A. Substance P and mitochondrial oxygen consumption: evidence for a direct intracellular role for the peptide. Peptides 1989;10:1003-6. (Pubitemid 20003381)
36. Kaasik A, Veksler V, Boehm E, Novotova M, Minajeva A, Ventura-Clapier R. Energetic crosstalk between organelles: architectural integration of energy production and utilization. Circ Res 2001;89:153-9. (Pubitemid 34135823)
37. Jahani-Asl A, Slack RS. The phosphorylation state of Drp1 determines cell fate. EMBO Rep 2007;8:912-3. (Pubitemid 47500472)
38. Saotome M, Safiulina D, Szabadkai G, Das S, Fransson A, Aspenstrom P, et al. Bidirectional Ca2+-dependent control of mitochondrial dynamics by the Miro GTPase. Proc Natl Acad Sci U S A 2008;105:20728-33.
39. Quintana A, Schwindling C, Wenning AS, Becherer U, Rettig J, Schwarz EC, et al. T cell activation requires mitochondrial translocation to the immunological synapse. Proc Natl Acad Sci U S A 2007;104:14418-23. (Pubitemid 350003276)
40. Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N, et al. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 2008;94:16-37.
41. Bieber T. Atopic dermatitis. N Engl J Med 2008;358:1483-94.
42. Kawakami T, Ando T, Kimura M, Wilson BS, Kawakami Y. Mast cells in atopic dermatitis. Curr Opin Immunol 2009;21:666-78.
43. Simpson EL. Atopic dermatitis: a review of topical treatment options. Curr Med Res Opin 2010;26:633-40.
44. Inagaki N, Shiraishi N, Igeta K, Nagao M, Kim JF, Chikumoto T, et al. Depletion of substance P, a mechanism for inhibition of mouse scratching behavior by tacrolimus. Eur J Pharmacol 2010;626:283-9.
45. Sengoku T, Kishi S, Sakuma S, Ohkubo Y, Goto T. FK506 inhibition of histamine release and cytokine production by mast cells and basophils. Int J Immunopharmacol 2000;22:189-201. (Pubitemid 30102265)
46. Pereira U, Boulais N, Lebonvallet N, Pennec JP, Dorange G, Misery L. Mechanisms of sensory effects of tacrolimus on the skin. Br J Dermatol 2010;163:70-7.
47. Gong J, Yang NS, Croft M, Weng IC, Sun L, Liu FT, et al. The antigen presentation function of bone marrow-derived mast cells is spatiotemporally restricted to a subset expressing high levels of cell surface FcepsilonRI and MHC II. BMC Immunol 2010;11:34.
48. Kempuraj D, Tagen M, Iliopoulou BP, Clemons A, Vasiadi M, Boucher W, et al. Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell dependent stimulation of Jurkat T cells. Br J Pharmacol 2008;155:1076-84.
49. Cassano N, Loconsole F, Coviello C, Vena GA. Infliximab in recalcitrant severe atopic eczema associated with contact allergy. Int J Immunopathol Pharmacol 2006;19:237-40.
50. Rigopoulos D, Korfitis C, Gregoriou S, Katsambas AD. Infliximab in dermatological treatment: beyond psoriasis. Expert Opin Biol Ther 2008;8:123-33. (Pubitemid 351242511)
51. Sockolov ME, Alikhan A, Zargari O. Non-psoriatic dermatologic uses of monoclonal antibody therapy. J Dermatolog Treat 2009;20:319-27.